V
Vivimed Labs
6.68
V
Vivimed Labs
6.68
VIVIMEDLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
55
PE Ratio
-1.60
PB Ratio
-0.65
Dividend Yield
-
ROE
90.88%
ROCE
-5.64%
Book Value (₹)
-10.37
Face Value (₹)
2.00
Analyse VIVIMEDLAB with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 20.94% | 7.77% | 7.77% | 7.77% | 7.57% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% |
| Public Investors | 57.91% | 65.19% | 65.18% | 65.06% | 68.75% |
| Government | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VIVIMEDLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
532660
NSE Scrip Name
VIVIMEDLAB
ISIN
INE526G01021



